Revised proposal for a Directive on "information" to patients

Some improvements, but risks of DTCA (direct-to-consumer advertising) remain

read english (164 KB) read french (173 KB)

Joint analysis

Revised proposals on "information" to patients: still an open door to advertising of prescription-only medicines by pharmaceutical companies
read (279 KB)

Final proposals on pharmacovigilance: Some progress, but a missed opportunity to genuinely strengthen patient safety

read (140 KB)

Towards direct-to-consumer advertising (DTCA) of prescription drugs in Europe?

read (150 KB)

Direct-to-consumer communication by pharmaceutical companies? Europeans deserve better

read (620 KB)

Pharmaceutical sector enquiry

read (235 KB)

Pharmacovigilance: a crucial issue for the health and safety of all Europeans

Prescrire and its partners continue in their campaign to reorient the European Commission’s proposals on pharmacovigilance toward public health and a real reinforcement of safety for European citizens.

Pharmacovigilance in Europe: overwhelming opposition to the EU Commission's proposals

read (211 KB)

Direct-to-Consumer Communication by pharmaceutical companies

European Commission pushes ahead despide civil society's opposition
read (112 KB)

Pharmacovigilance in Europa and patient safety: no to deregulation

read (128 KB)

Pharmaceutical companies' direct-to-consumer communication: No thanks!

read (156 KB)

EU Pharmaceutical Forum: public health is not its overriding priority

read  (241 KB)

Patient - 'information' by Big Pharma

english (130 KB)
spanish (128 KB)

Parliament’s stand against conflicts of interest: Is it enough to ensure medicines safety?

read (147 KB)

EMA suggestions on comparative clinical trials fall back behind ethical and scientific standards

Read (104 KB)

Submission of comments on 'EMA Reflection paper on the need for active control in therapeutic areas where use of placebo is deemed ethical and one or more established medicines are available'

read (141 KB)

European drug regulator challenged over revolving door case involving former Director

read (215 KB)

EMA’s policy on conflict of interest: improvements needed

read (157 KB)

Action is needed to enforce the European Medicine Agency’s policy on conflict of interest

read (178 KB)

Transparency of European drug regulatory authorities: improvements needed

Download the Joint Consultation (234 Kb)

EMA transparency draft is just window dressing

HAI Europe, ISDB and MiEF find that “EMEA’s draft transparency policy”  fails to restore citizens’ trust in its decision-making.

read (210 KB)

EMA: excessive secrecy beyond the law!

Trasparency should be the norm

read (255 KB)

Handling of the influenza A/H1N1 "pandemic": European citizens want to know more

read (43 KB)

What is more dangerous to your health: Flu or Tamiflu?

read (179 KB)